Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

79°
- Benton, AR (72018)
  Today
  
  Sun and clouds mixed. High 81F. Winds SSW at 15 to 25 mph. Higher wind gusts possible..
  
  Tonight
  
  Partly cloudy early followed by cloudy skies overnight. A stray shower or thunderstorm is possible. Low around 65F. Winds S at 5 to 10 mph.
  
  Updated: May 4, 2026 @ 1:29 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2026
Community Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Edwards Lifesciences (NY:EW)

83.32 -0.66 (-0.79%)

Streaming Delayed Price Updated: 3:19 PM EDT, May 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue

May 02, 2026

From Edwards Lifesciences Corporation

Via Business Wire

Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference

April 28, 2026

From Edwards Lifesciences Corporation

Via Business Wire

Top gainers and losers in the S&P500 index during Thursday's after-hours session. ↗

April 23, 2026

Via Chartmill

Edwards Lifesciences Corp (NYSE:EW) Shares Surge After Q1 Earnings Beat and Raised Guidance ↗

April 23, 2026

Via Chartmill

Topics Earnings

Edwards Lifesciences Reports First Quarter Results

April 23, 2026

From Edwards Lifesciences Corporation

Via Business Wire

Edwards Lifesciences Corp (NYSE:EW) Reports Mixed Q4 Results, Misses EPS Estimates ↗

February 10, 2026

Via Chartmill

The Quiet Shift Replacing Million-Dollar Heart Scanners With Software

April 16, 2026

Issued on behalf of VentriPoint Diagnostics Ltd.

From USA News Group

Via GlobeNewswire

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026

April 16, 2026

From Edwards Lifesciences Corporation

Via Business Wire

Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗

April 15, 2026

Discover the top S&P500 movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

Topics Lawsuit

The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)

April 01, 2026

As of April 1, 2026, Becton, Dickinson and Company (NYSE: BDX), commonly known as BD, finds itself at a historic crossroads. For decades, BD was viewed as a diversified healthcare conglomerate—a...

Via Finterra

Topics Economy Lawsuit Product Recall

Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits

March 30, 2026

From Edwards Lifesciences Corporation

Via Business Wire

This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗

March 15, 2026

This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing.

Via The Motley Fool

This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share ↗

March 15, 2026

RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.

Via The Motley Fool

Friday's session: top gainers and losers in the S&P500 index ↗

March 13, 2026

Via Chartmill

Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose

February 26, 2026

From Edwards Lifesciences Corporation

Via Business Wire

ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗

February 20, 2026

Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s...

Via The Motley Fool

Topics Regulatory Compliance

Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape

February 19, 2026

On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire...

Via MarketMinute

Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

February 19, 2026

From Edwards Lifesciences Corporation

Via Business Wire

Exploring the top movers within the S&P500 index during today's session. ↗

February 17, 2026

Via Chartmill

The Return of the Mega-Deal: How 2026’s Regulatory Pragmatism is Reshaping Corporate America

February 13, 2026

The U.S. mergers and acquisitions (M&A) landscape has entered a definitive new era in early 2026, marked by what analysts are calling a "Strategic Rebound." After years of aggressive antitrust...

Via MarketMinute

Topics Artificial Intelligence Economy

Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day

February 13, 2026

From Edwards Lifesciences Corporation

Via Business Wire

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH ↗

February 12, 2026

Via MarketBeat

Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights

February 12, 2026

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

From Halper Sadeh LLC

Via GlobeNewswire

Unusual volume S&P500 stocks in Wednesday's session ↗

February 11, 2026

Via Chartmill

Edwards Lifesciences (EW) Earnings Transcript ↗

February 10, 2026

Edwards Lifesciences (EW) Earnings Transcript

Via The Motley Fool

Edwards Lifesciences Reports Fourth Quarter Results

February 10, 2026

From Edwards Lifesciences Corporation

Via Business Wire

The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition

February 05, 2026

In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for...

Via MarketMinute

Topics Supply Chain

Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026

February 03, 2026

From Edwards Lifesciences Corporation

Via Business Wire

Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference

February 02, 2026

From Edwards Lifesciences Corporation

Via Business Wire

The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants

January 27, 2026

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN)...

Via MarketMinute

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Edwards Lifesciences (NY:EW)

All News about Edwards Lifesciences

Sections

Services

Follow Us